Recombinant multi-species LIX/CXCL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LIX/CXCL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein that is a member of the CXC subfamily of chemokines. Chemokines, which recruit and activate leukocytes, are classified by function (inflammatory or homeostatic) or by structure. This protein is proposed to bind the G-protein coupled receptor chemokine (C-X-C motif) receptor 2 to recruit neutrophils, to promote angiogenesis and to remodel connective tissues. This protein is thought to play a role in cancer cell proliferation, migration, and invasion. [provided by RefSeq, May 2013]
The Alternative Names of target: C-X-C motif chemokine 5,CXCL5,ENA-78,ENA-78(1-78),Epithelial-derived neutrophil-activating protein 78,LIX,Neutrophil-activating peptide ENA-78,SCYB5,Small-inducible cytokine B5

Target products collectionGo to LIX/CXCL5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0844-Ag-1/ GM-Tg-hg-SE0844-Ag-2 Human LIX/CXCL5 protein Human
GM-Tg-rg-SE0844-Ag-1/ GM-Tg-rg-SE0844-Ag-2 Rat LIX/CXCL5 protein Rat
GM-Tg-mg-SE0844-Ag-1/ GM-Tg-mg-SE0844-Ag-2 Mouse LIX/CXCL5 protein Mouse
GM-Tg-cynog-SE0844-Ag-1/ GM-Tg-cynog-SE0844-Ag-2 Cynomolgus/Rhesus macaque LIX/CXCL5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0844-Ag-1/ GM-Tg-felg-SE0844-Ag-2 Feline LIX/CXCL5 protein Feline
GM-Tg-cang-SE0844-Ag-1/ GM-Tg-cang-SE0844-Ag-2 Canine LIX/CXCL5 protein Canine
GM-Tg-bovg-SE0844-Ag-1/ GM-Tg-bovg-SE0844-Ag-2 Bovine LIX/CXCL5 protein Bovine
GM-Tg-equg-SE0844-Ag-1/ GM-Tg-equg-SE0844-Ag-2 Equine LIX/CXCL5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0844-Ag-1/ GM-Tg-hg-SE0844-Ag-2; GM-Tg-rg-SE0844-Ag-1/ GM-Tg-rg-SE0844-Ag-2;
GM-Tg-mg-SE0844-Ag-1/ GM-Tg-mg-SE0844-Ag-2; GM-Tg-cynog-SE0844-Ag-1/ GM-Tg-cynog-SE0844-Ag-2;
GM-Tg-felg-SE0844-Ag-1/ GM-Tg-felg-SE0844-Ag-2; GM-Tg-cang-SE0844-Ag-1/ GM-Tg-cang-SE0844-Ag-2;
GM-Tg-bovg-SE0844-Ag-1/ GM-Tg-bovg-SE0844-Ag-2; GM-Tg-equg-SE0844-Ag-1/ GM-Tg-equg-SE0844-Ag-2
Products Name LIX/CXCL5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name LIX/CXCL5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine LIX/CXCL5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.